Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients

Clinical trial NCT01526928 · TERMINATED

Trial details

NCT number: NCT01526928
Sponsor: Clovis Oncology, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Non Small Cell Lung Cancer

Start date: 2012-03-27
Primary completion: 2018-07-03
Enrollment: 612

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.